BlackRock’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.17B | Buy |
|
|||||
|
2025
Q2 | $910M | Buy |
|
|||||
|
2025
Q1 | $803M | Buy |
|
|||||
|
2024
Q4 | $1.11B | Buy |
|
|||||
|
2024
Q3 | $789M | Buy |
|
|||||
|
2024
Q2 | $699M | Sell |
|
|||||
|
2024
Q1 | $617M | Buy |
|
|||||
|
2023
Q4 | $435M | Buy |
|
|||||
|
2023
Q3 | $416M | Buy |
|
|||||
|
2023
Q2 | $303M | Buy |
|
|||||
|
2023
Q1 | $355M | Sell |
|
|||||
|
2022
Q4 | $368M | Sell |
|
|||||
|
2022
Q3 | $336M | Sell |
|
|||||
|
2022
Q2 | $324M | Buy |
|
|||||
|
2022
Q1 | $391M | Buy |
|
|||||
|
2021
Q4 | $322M | Sell |
|
|||||
|
2021
Q3 | $395M | Buy |
|
|||||
|
2021
Q2 | $394M | Sell |
|
|||||
|
2021
Q1 | $485M | Buy |
|
|||||
|
2020
Q4 | $359M | Sell |
|
|||||
|
2020
Q3 | $342M | Buy |
|
|||||
|
2020
Q2 | $464M | Sell |
|
|||||
|
2020
Q1 | $339M | Buy |
|
|||||
|
2019
Q4 | $353M | Buy |
|
|||||
|
2019
Q3 | $244M | Buy |
|
|||||
|
2019
Q2 | $323M | Buy |
|
|||||
|
2019
Q1 | $530M | Buy |
|
|||||
|
2018
Q4 | $520M | Buy |
|
|||||
|
2018
Q3 | $713M | Buy |
|
|||||
|
2018
Q2 | $777M | Buy |
|
|||||
|
2018
Q1 | $494M | Sell |
|
|||||
|
2017
Q4 | $565M | Buy |
|
|||||
|
2017
Q3 | $514M | Buy |
|
|||||
|
2017
Q2 | $913M | Sell |
|
|||||
|
2017
Q1 | $892M | Buy |
|
|||||
|
2016
Q4 | $54.1M | Buy |
|
|||||
|
2016
Q3 | $23.2M | Sell |
|
|||||
|
2016
Q2 | $28.7M | Sell |
|
|||||
|
2016
Q1 | $34.7M | Buy |
|
|||||
|
2015
Q4 | $41.6M | Sell |
|
|||||
|
2015
Q3 | $42.3M | Sell |
|
|||||
|
2015
Q2 | $50.6M | Buy |
|
|||||
|
2015
Q1 | $50.3M | Buy |
|
|||||
|
2014
Q4 | $32.3M | Buy |
|
|||||
|
2014
Q3 | $27.4M | Buy |
|
|||||
|
2014
Q2 | $9.42M | Buy |
|
|||||
|
2014
Q1 | $9.4M | Buy |
|